Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer.
- DOI
- 10.1136/jitc-2022-005128
- Published
- 2022 Sep
- Container
- Journal for immunotherapy of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/jitc-2022-005128,
title = {Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer.},
author = {Odeny TA and Lurain K and Strauss J and Fling SP and Sharon E and Wright A and Martinez-Picado J and Moran T and Gulley JL and Gonzalez-Cao M and Uldrick TS and Yarchoan R and Ramaswami R},
year = {2022},
journal = {Journal for immunotherapy of cancer},
doi = {10.1136/jitc-2022-005128},
url = {https://doi.org/10.1136/jitc-2022-005128}
}RIS
TY - JOUR TI - Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer. AU - Odeny TA AU - Lurain K AU - Strauss J AU - Fling SP AU - Sharon E AU - Wright A AU - Martinez-Picado J AU - Moran T AU - Gulley JL AU - Gonzalez-Cao M AU - Uldrick TS AU - Yarchoan R AU - Ramaswami R PY - 2022 JO - Journal for immunotherapy of cancer DO - 10.1136/jitc-2022-005128 UR - https://doi.org/10.1136/jitc-2022-005128 ER -
APA
TA, O., K, L., J, S., SP, F., E, S., A, W., J, M., T, M., JL, G., M, G., TS, U., R, Y., & R, R. (2022). Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2022-005128
Source records
- pubmed · retrieved 2026-09-25T09:06:21.856Z